文献速递核素与放射性配体治疗肿瘤 PET/CT

去势抵抗性前列腺癌孤立性肾上腺转移:177Lu-PSMA治疗反应优异且无肾上腺功能不全

Isolated Adrenal Metastases of Castration-Resistant Prostate Cancer: Excellent Response to 177 Lu-PSMA With No Adrenal Insufficiency.
PubMed 文献 · Clin Nucl Med · 2023-11-22

本文报告一名66岁去势抵抗性前列腺癌患者,化疗进展后68Ga-PSMA PET/CT显示双侧肾上腺转移灶强烈PSMA摄取,因手术和放疗存在确定性肾上腺功能不全高风险而接受4周期177Lu-PSMA治疗,68Ga-PSMA PET/CT显示双侧肾上腺转移灶接近完全缓解,随访期间未观察到肾上腺功能不全征象。

要点

  • 66岁去势抵抗性前列腺癌患者化疗进展后检出双侧肾上腺孤立性转移。
  • 因手术和放疗存在确定性肾上腺功能不全高风险,患者接受4周期177Lu-PSMA治疗。
  • 治疗后68Ga-PSMA PET/CT示双侧肾上腺转移灶接近完全缓解,随访未见肾上腺功能不全。

核心结论

  • 孤立性双侧肾上腺转移的去势抵抗性前列腺癌患者接受177Lu-PSMA治疗后获得接近完全缓解,且随访期间未出现肾上腺功能不全。

研究设计与样本

  • 本文报告一名66岁去势抵抗性前列腺癌患者的病例。

主要发现

  • 患者化疗进展后68Ga-PSMA PET/CT显示双侧肾上腺肿块强烈PSMA摄取。
  • 因手术和放疗存在确定性肾上腺功能不全高风险,患者接受4周期177Lu-PSMA治疗。
  • 治疗后68Ga-PSMA PET/CT显示双侧肾上腺转移灶接近完全缓解。
  • 随访期间未观察到肾上腺功能不全征象。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We present isolated bilateral adrenal metastases successfully treated with 177 Lu-PSMA in a 66-year-old man diagnosed with castration-resistant prostate cancer. The patient had progression under chemotherapy as depicted by 68 Ga-PSMA PET/CT showing intense bilateral PSMA uptake in the adrenal masses, and metastasis-directed therapies were considered as the first option for improving survival because the patient was oligometastatic. However, surgery and radiotherapy were not justifiable options due to the high risk of definitive adrenal insufficiency; therefore, the patient received 4 cycles of 177 Lu-PSMA treatment. 68 Ga-PSMA PET/CT showed near-complete response in bilateral adrenal metastases, and no sign of adrenal insufficiency was observed during follow-up.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Topal E, Has Simsek D, Vatansever S, et al. Isolated Adrenal Metastases of Castration-Resistant Prostate Cancer: Excellent Response to 177 Lu-PSMA With No Adrenal Insufficiency. Clin Nucl Med. 2023. PMID: 37991439. doi:10.1097/RLU.0000000000004964

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。